Prudential Financial’s Bionano Genomics BNGO Stock Holding History

Prudential Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.8K	Buy	+28,000	New	+$35.9K	﹤0.01%	2354
2024 Q3	–	Sell	-238	Closed	-$9.7K	–	2717
2024 Q2	$9.7K	Buy	+238	New	+$13.1K	﹤0.01%	2679
2024 Q1	–	Sell	-205	Closed	-$23.2K	–	2680
2023 Q4	$23.2K	Buy	+205	New	+$21.4K	﹤0.01%	2609
2023 Q2	–	Sell	-35	Closed	-$23.5K	–	2627
2023 Q1	$23.5K	Hold	35	–	–	﹤0.01%	2559
2022 Q4	$31K	Hold	35	–	–	﹤0.01%	2540
2022 Q3	$39K	Hold	35	–	–	﹤0.01%	2576
2022 Q2	$29K	Hold	35	–	–	﹤0.01%	2621
2022 Q1	$55K	Hold	35	–	–	﹤0.01%	2568
2021 Q4	$63K	Sell	35 -3	-8%	-$8.02K	﹤0.01%	2596
2021 Q3	$125K	Buy	38 +1	+3%	+$3.5K	﹤0.01%	2514
2021 Q2	$162K	Buy	+37	New	+$146K	﹤0.01%	2474

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Prudential Financial's BNGO Position: Q1 2026 in Review

Prudential Financial opened a new position in Bionano Genomics (BNGO) in Q1 2026: 28,000 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #2354 among its holdings. This is a return to the name: Prudential Financial previously reported a position in BNGO as recently as Q2 2024.

Prudential Financial first reported a position in BNGO in Q2 2021 and has held it in 11 quarters since. The position peaked at $162K in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Prudential Financial held 28,000 shares of Bionano Genomics worth $32.8K as of Q1 2026.
Bionano Genomics was a new Prudential Financial position in Q1 2026.
Bionano Genomics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2354 holding.
Prudential Financial first reported a position in Bionano Genomics in Q2 2021 and has held it in 11 quarters since.
Prudential Financial's Bionano Genomics position peaked at $162K in Q2 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.